Oncologists: Paid Medical Second Opinion Work

Why this specialty

Why Oncology fits the network

No specialty has a stronger second-opinion culture than oncology — patients are routinely encouraged to seek one, major centers maintain formal programs for them, and the decisions at stake justify the effort. What has never scaled is access: a patient far from an academic center faces weeks of records-gathering and travel to get a qualified independent review of their treatment plan. SecondOpinionMedical.AI closes that distance by bringing the assembled case to a verified, board-certified oncologist — you — for a documented written opinion, wherever the patient lives.

The records problem is most severe in oncology, and it is the problem the platform is specifically built to solve. A responsible oncology opinion needs the pathology reports, staging imaging, molecular and genomic panels, treatment summaries, and infusion records — typically fragmented across a hospital system, a reference lab, and an imaging center. The AI-driven pipeline retrieves those records and synthesizes them into a structured package with a framed clinical question, using multi-engine evidence synthesis to surface what is relevant. You review a case, not a banker’s box.

Demand concentrates exactly where oncologic judgment is hardest to substitute: whether a regimen matches current evidence for a molecularly defined subtype, whether staging supports the stated treatment intent, whether a line change is warranted now. Every reviewer clears NPI verification against NPPES and OIG-LEIE screening before seeing a case, because the verified credential is precisely what the patient is paying for.

Physicians arrive here searching for different things — “oncologist medical second opinion reviewer”, “remote oncology case review”, “cancer second opinion”, “oncology telehealth side income”, “tumor board second opinion”, “medical oncology review” — and this page covers all of them.

On the platform

Representative case types

Newly diagnosed treatment-plan reviews

A patient facing a first regimen wants independent confirmation that the proposed plan fits guideline-concordant options for their tumor type, stage, and molecular profile before the first cycle starts — the single most requested oncology second opinion.

Molecular and biomarker interpretation

Next-generation sequencing panels with findings the patient does not understand and is not sure their plan reflects: whether an actionable alteration changes the recommended therapy, and whether anything reportable was left unaddressed.

Staging confirmation

Review of the imaging, pathology, and workup underlying the assigned stage — because stage assignment drives treatment intent, and a discrepancy between curative and palliative framing is the highest-stakes discordance in the field.

Progression and line-change decisions

A surveillance scan shows growth, or markers rise on therapy. The review weighs true progression against alternative explanations and whether switching lines now, versus consolidating or continuing, best fits the evidence and the patient’s stated goals.

Clinical-trial pathway assessment

Whether the patient’s profile plausibly merits investigating trial options alongside standard therapy — an independent read on a question treating teams under time pressure cannot always explore fully.

Indolent-disease management second looks

Watch-and-wait versus treat decisions in CLL, follicular lymphoma, and low-risk prostate cancer, where patients often struggle with observation as an active strategy and want a documented independent view of it.

Practice fit

How it fits your week — and how it pays

Workflow fit

Oncology second opinions on this platform are asynchronous, written, and self-paced — structurally similar to preparing a tumor-board presentation for a single patient, minus the meeting. The case package arrives assembled; you review it within a defined response window sized for the material, on whatever schedule your clinic, inpatient service, or research time allows; and you render a structured, signed written opinion. There is no patient panel, no cross-coverage, no infusion-suite involvement, and no assumption of care. Academic and community oncologists alike run this as a bounded consultative sideline that draws on exactly the case-analysis work they already do daily.

Compensation, plainly

Compensation is a per-case honorarium, fixed and visible before you accept each case, and scaled to the review’s complexity — a multi-line, molecularly complex case is not priced like a focused staging question. There are no quotas, no minimums, and no advertised rate tables; the platform’s position is that you should see the exact honorarium on a real case before committing an hour to it, and decide case by case.

Board certifications we recognize for Oncology:

ABIM — Medical OncologyABIM — HematologyAmerican Board of Radiology — Radiation OncologyAmerican Board of Surgery — Complex General Surgical Oncology

Questions

Oncology FAQs

Board certification in a recognized oncologic discipline — medical oncology or hematology through ABIM, radiation oncology through ABR, or complex general surgical oncology through the American Board of Surgery. Cases route by discipline and by the tumor types you indicate during onboarding, and every reviewer clears NPI and OIG verification first.

You indicate the tumor types you actively practice in, and matching respects it — a breast-focused medical oncologist is not handed a sarcoma regimen question. The case package synthesizes the relevant records; the evidence judgment it exists to obtain is yours.

You say so — flagging that a pathology addendum, a missing scan, or an unreported biomarker is needed before a sound opinion can be rendered is itself a clinically valuable finding, and the platform treats it as part of the review rather than a failed case.

A second opinion here is a documented consultative review of the assembled record: you do not assume care, prescribe, or direct treatment. The opinion is delivered to the patient to discuss with their treating team, under your name and certification, with its scope stated in the document itself.

It tracks the complexity of the disease course — a newly diagnosed staging-and-plan review is a different commitment than a fourth-line question with years of records. Scope and honorarium are both visible before you accept, so the time-to-compensation judgment is always yours to make in advance.

Across the network

Also recruiting

Radiology Gastroenterology Pulmonology Dermatology

Join the Network

Apply once — verification is the front door

Tell us about your practice on the product page. Every application is verified against the NPPES NPI registry and screened against the OIG LEIE exclusions list before approval. Patients only ever see verified, board-certified physicians.

Explore Second Opinion